SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
MEDIVATION
(NQNM:MDVN Last Sale: 60.04 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (MDVN : $60.04)
$3,618 million Market Cap at September 12, 2013
Employs 6.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
501 Second Street, Suite 211 Research Report Earnings Snapshot - Last 11/06/18
San Francisco, CA 94107 Fact Sheet
Phone: (415) 543-3470 Financial Statements
Peer Comparison
Annual Reports

David T. Hung, Pres./CEO, C. Patrick Machado, CFO
February 28, 2006, received comments from the FDA regarding new drug application (IND) filed on January 31, 2006 to begin human clinical development of Dimebon for Huntington's disease. Listed on Amex March 15, 2006 following 4.9 million share Secondary. Also has a clinical program on Alzheimer's disease. Formerly, ORION ACQUISITION CORP II, which had an IPO at $10 October 9, 1996. Raised $8 MM, selling 0.8 MM shares, 89% of the outstanding. Lead Manager: H.J. Meyers.
Historical Charts    Technical Analysis
No Historical Data available for MDVN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common MDVN $60.04 $ 0 $59.89 $61.14 561,249 $41.89 $61.46 60,252
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $3,617,530

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
21-SEP-12 MDVN Split 2 for 1

A7
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex